Ultragenyx Pharmaceutical Inc.
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
07/22/2021 | Press release | Distributed by Public on 07/22/2021 14:18
Please select the service you want to use:
Smartlinks | Smith-Midland Corporation | News | Local News | Finance | Stock Markets | Security Markets | Stock Markets | Security Markets | Company News | Shareholders | Internal Dealings | Building Materials | Manufacturing | Public Companies | Cement, Lime and Plaster Manufacturers | NYSE American | NYSE ARCA Equities | Nasdaq Capital Market | BZX Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | NYSE National | Nasdaq BX | Nasdaq PSX | FINRA Alternative Display Facility (ADF) | NYSE Chicago
Back
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact